Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Thoughts on UBX?
-
Illumina Inc. (ILMN $134.46)
- $134.46 P/E (TTM): 22.04X Cap: $20.55B
- View ILMN Profile
- View Questions on ILMN
-
Pacific Biosciences of California Inc. (PACB $1.68)
- $1.68 Cap: $492M
- View PACB Profile
- View Questions on PACB
-
Invitae Corporation (NVTA)
- Cap: $5M
- View NVTA Profile
- View Questions on NVTA
-
CRISPR Therapeutics AG (CRSP $60.14)
- $60.14 Cap: $5.77B
- View CRSP Profile
- View Questions on CRSP
-
Opko Health Inc. (OPK $1.20)
- $1.20 Cap: $910M
- View OPK Profile
- View Questions on OPK
-
Unity Biotechnology Inc. (UBX)
-
Intellia Therapeutics Inc. (NTLA $13.78)
- $13.78 Cap: $1.62B
- View NTLA Profile
- View Questions on NTLA
-
ARK Genomic Revolution ETF (ARKG $29.98)
- $29.98 P/E (TTM): 23.39X Cap: $1.34B
- View ARKG Profile
- View Questions on ARKG
Q: Hi guys. Would you be able to tell me your ratings on these medical stocks for growth and risk please. It would be a 3 year time frame minimum. Thks again for the great job you do.
Q: Thoughts on UBX:US?
Insiders
Share Information
SEC Filings
News and Media